FDA Orthopedic and Rehabilitation Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
Meeting scheduled for May 5 is postponed "for administrative reasons," according to an April 18 release. The panel was to convene to review HealthTronics' premarket approval application for use of the OssaTron orthopedic lithotripter for treatment of plantar fasciitis (heel spurs). The meeting will be rescheduled for a later date